Moderna and Merck to Develop Together a Cancer Vaccine

Click Here

In a phase two trial, the vaccine from Modernais is being examined in conjunction

Click Here

Merck’s Keytruda to treat patients with high-risk melanoma, the most lethal type of skin cancer.

Click Here

The stock of Moderna surged 16% in morning trading before losing some of that gain.

Click Here

It accounted for 35% of all sales for the business in the second quarter.

Moderna and Merck to Develop Together a Cancer Vaccine. The Food and Drug Adm. has given it to treat variety of cancers

Click Here